1-6 of 6
Dai Chihara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment Patterns and Outcomes in Follicular Lymphoma with POD24: An Analysis from The LEO Consortium

Jonathan R Day, Melissa C. Larson, Urshila Durani, Jean L Koff, Yucai Wang, Thomas M. Habermann, Izidore S Lossos, Loretta J. Nastoupil, Christopher S Strouse, Dai Chihara, Peter Martin, John P. Leonard, Jonathon B Cohen, Brad S. Kahl, Jia Ruan, Richard Burack, Jonathan W. Friedberg, James R Cerhan, Christopher R. Flowers, Brian L Link, Matthew J. Maurer, Carla Casulo
Journal: Blood Advances
Blood Adv bloodadvances.2024014053.
https://doi.org/10.1182/bloodadvances.2024014053
Published: 2024
Includes: Supplemental data
Journal Articles

Transformation in marginal zone lymphoma: results from a prospective cohort and a meta-analysis of the literature

Clinical Trials & Observations
Côme Bommier, Brian K. Link, Brianna J. Gysbers, Matthew J. Maurer, Melissa C. Larson, Arushi Khurana, Yucai Wang, Carrie A. Thompson, Dai Chihara, Juan P. Alderuccio, Jean L. Koff, Narendranath Epperla, Annarita Conconi, Izidore S. Lossos, Grzegorz S. Nowakowski, Andrew L. Feldman, Thomas M. Habermann, Rebecca L. King, James R. Cerhan
Journal: Blood Advances
Blood Adv (2024) 8 (23): 5939–5948.
https://doi.org/10.1182/bloodadvances.2024013188
Published: 2024
Includes: Supplemental data
Journal Articles

Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis

Clinical Trials & Observations
Jorge A. Florindez, Dai Chihara, Isildinha M. Reis, Izidore S. Lossos, Juan Pablo Alderuccio
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4423–4432.
https://doi.org/10.1182/bloodadvances.2024013499
Published: 2024
Includes: Supplemental data
Journal Articles

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun, Sherry Adkins, Swapna Johncy, Taylor Cain, Raphael E. Steiner, Sairah Ahmed, Dai Chihara, Luis E. Fayad, Swaminathan P. Iyer, Sandra Horowitz, Loretta J. Nastoupil, Ranjit Nair, Ahmed Hassan, Taher E. Daoud, Misha Hawkins, Maria A. Rodriguez, Elizabeth J. Shpall, Jeremy L. Ramdial, Partow Kebriaei, David S. Hong, Jason R. Westin, Sattva S. Neelapu, Michael R. Green
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6785–6789.
https://doi.org/10.1182/bloodadvances.2023010653
Published: 2023
Includes: Supplemental data
Journal Articles

Outcomes of breakthrough COVID-19 infections in patients with hematologic malignancies

Kelly S. Chien, Christine B. Peterson, Elliana Young, Dai Chihara, Elizabet E. Manasanch, Jeremy L. Ramdial, Philip A. Thompson
Journal: Blood Advances
Blood Adv (2023) 7 (19): 5691–5697.
https://doi.org/10.1182/bloodadvances.2022008827
Published: 2023
Journal Articles

Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant

Clinical Trials & Observations
Dai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, Constance Yuan, Hao-Wei Wang, Hong Zhou, Mark Raffeld, Liqiang Xi, Seth M. Steinberg, Julie Feurtado, Lacey James-Echenique, Chin-Hsien Tai, Keyur P. Patel, Raul C. Braylan, Katherine R. Calvo, Irina Maric, Alina Dulau-Florea, Robert J. Kreitman
Journal: Blood Advances
Blood Adv (2021) 5 (23): 4807–4816.
https://doi.org/10.1182/bloodadvances.2021005039
Published: 2021